Risk of infections in patients treated with ticagrelor vs. clopidogrel: a systematic review and meta-analysis

Li, HL; Feng, Q; Tsoi, MF; Fei, Y; Cheung, BMY

Feng, Q; Cheung, BMY (corresponding author), Univ Hong Kong, Queen Mary Hosp, LKS Fac Med, Div Clin Pharmacol & Therapeut,Dept Med, Pokfulam Rd, Hong Kong 00000, Peoples R China.; Cheung, BMY (corresponding author), Univ Hong Kong, LKS Fac Med, State Key Lab Pharmaceut Biotechnol, Pokfulam Rd, Hong Kong 00000, Peoples R China.; Cheung, BMY (corresponding author), Univ Hong Kong, LKS Fac Med, Inst Cardiovasc Sci & Med, Pokfulam Rd, Hong Kong 00000, Peoples R China.

EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021; 7 (3): 171

Abstract

Aims Ticagrelor has been shown to reduce the risk of pneumonia and improve lung function, but the findings across studies were inconsistent. The objec......

Full Text Link